Athens, Greece

Panagiotis Marakos

This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignees: Beckman Research Institute, City of Hope, National and Kapodistrian University of Athens, University of Dundee. Active years: 2021-2025.

USPTO Granted Patents = 2 

% Patents Active = 100.0

Average Co-Inventor Count = 7.5

ph-index = 1


Company Filing History:


Years Active: 2021-2025

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Panagiotis Marakos

Introduction

Panagiotis Marakos is a notable inventor based in Athens, Greece. He has made significant contributions to the field of chemistry, particularly through his innovative work on pyridopyrazine compounds. His research has implications for various applications, showcasing his expertise and dedication to advancing scientific knowledge.

Latest Patents

Marakos holds a patent for "Pyridopyrazine compounds and uses thereof." This patent discloses various pyridopyrazines and methods for utilizing these compounds, highlighting his innovative approach to chemical research. The patent reflects his commitment to developing new solutions in the field.

Career Highlights

Throughout his career, Panagiotis Marakos has worked with esteemed organizations such as City of Hope and the National and Kapodistrian University of Athens. His experience in these institutions has allowed him to collaborate with leading experts and contribute to groundbreaking research.

Collaborations

Marakos has had the opportunity to work alongside talented individuals, including Sangkil Nam and David A. Horne. These collaborations have enriched his research and expanded the impact of his work in the scientific community.

Conclusion

Panagiotis Marakos is a distinguished inventor whose work on pyridopyrazine compounds exemplifies his innovative spirit. His contributions to chemistry and collaboration with esteemed institutions and individuals underscore his importance in the field.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…